Dividend22 May 2026, 03:03 pm
Sun Pharma Recommends Final Dividend of ₹5 per Share
AI Summary
Sun Pharmaceutical Industries Ltd. has recommended a final dividend of ₹5 per equity share of Re. 1 each for the financial year 2025-26, subject to shareholder approval at the 34th Annual General Meeting. This decision was made during the Board of Directors meeting held on May 22, 2026, where the audited financial results for the quarter and year ended March 31, 2026, were also approved. The dividend, once approved, will be paid within the timeline prescribed under the Companies Act, 2013.
Key Highlights
- Sun Pharma recommends a final dividend of ₹5 per share for FY 2025-26.
- Dividend is subject to shareholder approval at the 34th AGM.
- Audited financial results for the quarter and year ended March 31, 2026, were approved.
- Auditors issued an unmodified opinion on the financial results.
Price Impact
More from SUNPHARMA